\(
\def\WIPO{World Intellectual Property Organisation}
\)
Intellectual Property, Pharmaceuticals and Public Health : Access to Drugs in Developing Countries.
2011
G 25 SHA.I
Available at WIPO Library
Items
Details
Title
Intellectual Property, Pharmaceuticals and Public Health : Access to Drugs in Developing Countries.
Author
Description
352 pages : illustrations ; 24 cm
ISBN
9780857938794 Print
9780857938619 eBook
9780857938619 eBook
Alternate Call Number
G 25 SHA.I
Summary
This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights. With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies. Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law.
Bibliography, etc. Note
Includes bibliographical references and index.
Formatted Contents Note
1. Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment
2. Pharmaceutical Production and Access to Essential Medicines in South Africa
3. Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy
4. The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in Colombia
5. The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPS
6. Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS Program
7. The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies
8. Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience
9. Access to Indian Generic Drugs: Emerging Issues
10. Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in China
11. Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country
12. The TRIPS Agreement and Health Innovation in Bangladesh
Index
2. Pharmaceutical Production and Access to Essential Medicines in South Africa
3. Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy
4. The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in Colombia
5. The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPS
6. Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS Program
7. The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies
8. Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience
9. Access to Indian Generic Drugs: Emerging Issues
10. Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in China
11. Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country
12. The TRIPS Agreement and Health Innovation in Bangladesh
Index
Published
Cheltenham, UK : Edward Elgar, 2011.
Language
English
Record Appears in